Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Veralox Therapeutics Appoints Michael Hanna as Chief Medical Officer
Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies […]
Medable Hires Sanskriti Thakur as Chief Growth Officer to Lead Market Expansion
Medable Inc., the leading cloud platform for patient-centered drug development, today announced the hiring of Sanskriti […]
Spring Health Announces Harshit Shah as New Chief Technology Officer
Spring Health, a leading provider of behavioral health benefits with the most comprehensive solution for […]
Sir Richard Sykes Appointed Chair of Vaccine Taskforce
Sir Richard will use his extensive experience in biotechnology and pharmaceuticals to lead the significant […]
Dr. Paul Burton to Join Moderna as Chief Medical Officer
Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today […]
Advent France Biotechnology (AFB) Appoints Sidonie Fabre as CFO
Advent France Biotechnology (AFB), an AMF-regulated investment company dedicated to life sciences, today announces the […]
Theseus Pharmaceuticals Appoints Brad Dahms as Chief Financial Officer
Theseus Pharmaceuticals, a biotechnology company shaping the future of targeted oncology by developing best-in-class, pan-variant […]
Vortex Biosciences Announces Dr. Adrian Kinkaid as New CEO
Vortex Biosciences, the cancer diagnosis biotechnology business, has announced the appointment of Dr Adrian Kinkaid […]
Eddie Gray Appointed Chair of Antivirals Taskforce
The UK government has appointed Eddie Gray as the new chair of the Antivirals Taskforce. […]
Babylon Hires Former White House Health Official Darshak Sanghavi as New Chief Medical Officer
Babylon today announced the hiring of Darshak Sanghavi, MD as the company’s new Global Chief […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more